5
 
Search:

Health Care Antitrust Issues

2005 COMMISSION ACTIONS
[ Other Years]

December 2, 2005

  • In re Tamoxifen Citrate Antitrust Litigation, No. 03-7641 (United States Court of Appeals for the Second Circuit): Brief of Amicus Curiae Federal Trade Commission in Support of Plaintiffs-Appellants' Petition for Panel Rehearing and Rehearing En Banc

December 1, 2005

November 18, 2005

October 21, 2005

October 4, 2005

September 23, 2005

September 20, 2005

August 19, 2005

  • Staff Opinion Letter to North Mississippi Health Services Regarding the Purchase of Drugs and Their Transfer or Sale At Cost to the Good Samaritan Clinic

August 5, 2005

July 19, 2005

July 5, 2005

June 17, 2005

June 3, 2005

May 24, 2005

  • Prepared Statement of the Federal Trade Commission On New Entry Into Hospital Competition, Presented by John D. Graubert, Principal Deputy General Counsel of the Commission, Before the Subcommittee on Federal Financial Management, Government Information, and International Security of the Committee on Homeland Security and Governmental Affairs, United States Senate (May 24, 2005)

May 20, 2005

May 19, 2005

May 2, 2005

April 22, 2005

  • Schering-Plough Corp., Upsher-Smith Laboratories, Inc., Petitioners, v. Federal Trade Commission, Respondent. (United States Court of Appeals for the Eleventh Circuit)
  • The Non-Profit Institutions Act Exemption From the Robinson-Patman Act: Bureau of Competition Staff Advisory Opinion to Stevens Hospital, of Edmonds, Washington, Concerning the Applicability of the Non-Profit Institutions Act to Stevens Hospital's Proposed Pricing of Pharmaceuticals
    • Text of the Staff Advisory Opinion, From Acting Assistant Director David Pender
    • Text of the Incoming Letter From Stevens Hospital
    • News Release

April 19, 2005

April 7, 2005

  • Federal Trade Commission Letter to the Food and Drug Administration -- in FDA Docket No. 2005P-0008/CP-1 (Petition Filed by IVAX Pharmaceuticals) -- Urging the FDA to Reject A Rule Proposed by IVAX That Would Prevent the FDA From Delisting Patents from the Orange Book

April 5, 2005

March 2 , 2005

February 11, 2005

February 4, 2005

January 14, 2005

January 11, 2005

January 7 , 2005

  • Agreements Filed with the Federal Trade Commission under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003: Summary of Agreements Filed in FY 2004: A Report by The Bureau of Competition

Last Update: Friday, October 6, 2006